<DOC>
	<DOCNO>NCT02627378</DOCNO>
	<brief_summary>A highly pathogenic human coronavirus cause respiratory disease emerge Saudi Arabia 2012 . This viral infection term Middle East respiratory syndrome coronavirus ( MERS-CoV ) associate high mortality rate approximately 36 % report patient . The World Health Organization ( WHO ) report 1,374 laboratory-confirmed worldwide infection , include least 490 related death , September , 2012 , July 24 , 2015.2 The high incidence MERS-CoV infection Saudi Arabia may relate multiple factor , include seasonality , increase proactive screening , poor infection control measure , low relative humidity , high temperature . Infected patient MERS-CoV usually abnormal finding chest radiography , range subtle extensive unilateral bilateral abnormality . MERS progress rapidly respiratory failure , approximately 2/3 infected patient , high mortality rate , particularly immunocompromised patient . Extracorporeal membrane oxygenation ( ECMO ) emerge rescue therapy patient refractory hypoxemia H1N1 epidemic.The use veno-venous ( VV ) -ECMO provide respiratory support patient respiratory failure , whereas use veno-arterial ( VA ) -ECMO could helpful cardiorespiratory failure.10 However , survival rate infect patient H1N1 require use ECMO varies considerably among Caucasian Asian country ( 90 % survival Sweden 83 % UK13 vs. 35 % Japan ) . This large discrepancy could explain lack satisfactory equipment , therapeutic guideline , train staff , effective system allow patient transfer dedicate ECMO centre . Guery co-investigators describe use ECMO two French patient cardiorespiratory failure secondary MERS-CoV infection.This extend treatment refractory hypoxemic respiratory failure Saudi MERS-CoV outbreak .</brief_summary>
	<brief_title>Saudi Outcomes ECMO-treated MERS-CoV Patients</brief_title>
	<detailed_description>The Saudi Ministry Health implement national ECMO program since 2014 three major city include Jeddah , Al Madinah Riyadh report infected case MERS-CoV . The Saudi ECMO program provide rapid transportation chain system ( Medevac system ) , adequate number intensive care bed ECMO machine , highly trained perfusionists staff . The investigator hypothesize early use ECMO treatment severe acute hypoxemic respiratory failure , define ratio PaO2 fraction inspire oxygen ( PaO2/FiO2 ratio ) less 80 despite optimize ventilator management , infected patient MERS-CoV , would associate reduced in-hospital mortality rate . Patient Selection : The investigator obtain centralized ethic approval Ministry Health avoid delay facilitate conduct timely important study . Eligible patient legal guardian contact request participation obtain write consent . Patients 18 year old receive ECMO support MERS-CoV associate hypoxemic respiratory failure include . MERS-CoV infection define use WHO case definition . A positive polymerase chain reaction ( PCR ) nasopharyngeal oropharyngeal swab , sputum , tracheal aspirate , bronchial alveolar lavage sufficient establish diagnosis infection . Description Standardized National Protocol The participate Saudi center adopt standardize protocol base evidence-based guideline treatment acute respiratory distress syndrome ( ARDS ) associate H1N1 virus infection use low-tidal volume , lung-protective mechanical ventilation initial strategy . A lung-protective strategy apply use volume assist-control mode , pressure-controlled synchronized intermittent mandatory ventilation mode pressure-controlled ventilation mode , tidal volume 6 8 mL/kg predict body weight variable FiO2 positive end-expiratory pressure ( PEEP ) achieve arterial oxygen saturation ( SaO2 ) 88 % 95 % partial pressure oxygen ( PaO2 ) 55 80 mm Hg.Then full spectrum ventilator mode , include airway pressure release ventilation , prone ventilation high frequency ventilation use . If , despite measure , patient achieve ratio PaO2 fraction inspire oxygen ( FiO2 ) ( PaO2/FiO2 ratio ) great 100 `` safe '' setting ( i.e . FiO2 le 80 % , peak inspiratory ( Ppk ) plateau ( Ppl ) pressure less 40 35 cm H2O , respectively tidal volume le 6 8 ml/kg ) , patient assess eligibility ECMO support . Veno-venous ( VV-ECMO ) use respiratory support respiratory failure , whereas veno-arterial ( VA-ECMO ) use cardiorespiratory failure . Once adequate ECMO support institute , ventilator set low `` recruitment '' setting . When patient begin show evidence pulmonary recovery , ECMO support wean gradual reducing blood flow , gas flow , FIO2 membrane , PaO2/FiO2 ratio great 200 FiO2 50 % pressure le 38 cm H2O . Selection Historical Cohort The control group identify retrospectively , patient receive ECMO due lack access fulfill criterion initiate treatment select . Data Collection : National database use identify patient meet eligibility criterion . Trained research investigator collect relevant datafor eligible patient . The investigator use pre-designed case report form ( CRF ) abstract data . The investigator collect data : baseline characteristic include age , sex , height , weight , ethnicity , well presence number predefined comorbidities , ICU pharmacologic intervention , ventilation data include day mechanical ventilation , ventilation mode , mean value tidal volume , positive end expiratory pressure ( PEEP ) level , FiO2 , PaO2/FiO2 ratio , initiation ECMO support , administration antiviral antibiotic medication , type , gas flow ( liter/min ) , blood flow ( liter/min/m2 ) duration ECMO , circulatory support , length ICU hospital stay , mortality hospital stay . In addition , need renal replacement therapy ; tracheostomy ; bacterial co-infection duringICU stay ; ventilator-associated pneumonia record . The investigator document whether ECMO treatment initiatedatthe participate centeror whether patient transfer ECMO center . Data eligible patient record retrospectively ICU stay . Data hospital discharge death record well . Statistical Analysis : Descriptive data report number percentage dichotomous variable ; median [ interquartile range ] mean ( SD ) continuous variable . All outcome data Cohort-Controlled groupand ECMO group compare use independent Student test , Mann Whitney U test X2 test appropriate . P value &lt; 0.05 consider statistically significant . To determine predictor need ECMO factor associate death ECMO-treated patient enter multivariate stepwise backward logistic regression model .</detailed_description>
	<mesh_term>Anoxia</mesh_term>
	<mesh_term>Coronavirus Infections</mesh_term>
	<criteria>Positive infection Middle East Respiratory Syndrome virus Refractory hypoxemic respiratory failure Eligible use extracorporeal membrane oxygenation support ( ECMO ) Neonates Children Patients treat ECMO primary cardiac failure Following heart transplantation Following lung transplantation Following cardiac surgery Patients alternative diagnosis virus isolate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>